Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential

Jason Lohmueller(University of Pittsburgh), Olivera J. Finn(University of Pittsburgh)
Scientific Reports
August 22, 2016
10.1038/srep31740
Cited by 44

Related Papers

Cancer vaccines: between the idea and the reality
|Nature reviews. Immunology|2003|633
MUC1 Protein Expression in Tumor Cells Regulates Transcription of Proinflammatory Cytokines by Forming a Complex with Nuclear Factor-κB p65 and Binding to Cytokine Promoters
|Journal of Biological Chemistry|2011|95
Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions
|Antibodies|2024|5